Learn More
Seracare Life Sciences Inc Seraseq ctDNA Mutation Mix v2 WT | 1 x 25 µL
Supplier: Seracare Life Sciences Inc 07100144
To overcome the lack of patient-like reference materials for liquid biopsy, including drawbacks of existing methodologies such as sonication, SeraCare has developed a breakthrough technology that produces the most patient-like materials compared to native ctDNA. The Seraseq ctDNA Mutation Mix v2 is a highly multiplexed product for NGS-based ctDNA assays targeting cancer-relevant somatic mutations. This specific ctDNA Mutation Mix v2 product it the wild-type with an allele frequency of 0%.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.